Boehringer Ingelheim news

The new plant cuts CO2 emissions by 70%, saving 50,000 tons annually. It will cover 95% of energy needs from renewables. The goal is CO2 neutrality by 2030 with global energy-saving projects.

The new facility will develop and produce innovative tablet drugs for global markets, focusing on complex production technologies and maintaining the value chain in Germany.

A new 5,700 sq m facility in Lyon will boost avian vaccine production, creating 42 jobs. The environmentally friendly site will triple inactivated vaccine capacity by 2020.